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ABSTRACT
Alkylating agents often generate 3-methylcytosine
(3meC) lesions that are efficiently repaired by AlkB
homologues. If AlkB homologue proteins are not
functional, or the number of 3meC lesions exceeds
the cellular repair capacity, the damage will persist
in the genome and become substrate of DNA poly-
merases (Pols). Though alkylating agents are
present in our environment and used in the clinics,
currently nothing is known about the impact of
3meC on the accuracy and efficiency of human
Pols. Here we compared the 3meC bypass
properties of six human Pols belonging to the
three families: B (Pol d), X (Pols b and j) and Y
(Pols i, i and g). We show that under replicative con-
ditions 3meC impairs B-family, blocks X-family, but
not Y-family Pols, in particular Pols g and i. These
Pols successfully synthesize opposite 3meC; Pol i
preferentially misincorporates dTTP and Pol g
dATP. The most efficient extenders from 3meC
base-paired primers are Pols i and g. Finally, using
xeroderma pigmentosum variant patient cell
extracts, we provide evidence that the presence of
functional Pol g is mandatory to efficiently overcome
3meC by mediating complete bypass or extension.
Our data suggest that Pol g is crucial for efficient
3meC bypass.
INTRODUCTION
Living organisms are exposed to alkylating agents present
in shape of endogenous sources, such as cellular metabol-
ism, exogenously in the environment, and in clinics as one
of the most frequently used cancer chemotherapeutic
drugs (1,2). Exposure of genomic DNA to alkylating
agents often results in cytotoxic and/or carcinogenic mu-
tations (3). Consequently, alkylation chemotherapy was
shown to potentially induce secondary cancers
characterized by genome instability and mutation accu-
mulation (4). Alkylation DNA lesions, induced by SN2
alkylating agents, include 3-methylcytosine (3meC),
3-methylthymine, 1-methyladenine and 1-methylguanine
(5). 3meC lesions are predominantly generated in single-
stranded (ss) DNA during replication, repair and tran-
scription. In double-stranded (ds) DNA, the reactive site
is involved in base pairing and thus protected from modi-
ﬁcation (6). The 3meC lesions are efﬁciently repaired via
direct oxidative reversal, mediated by iron(II) and
2ketoglutarate (2KG)dependent dioxygenases: alkylation
protein B (AlkB) in prokaryotes (7) and the AlkB homo-
logues (ALKBH) 2 and 3 in eukaryotes (8,9). AlkB deﬁ-
cient Escherichia coli cells have elevated amount of
alkylated lesions, display increased mutation frequency
and are hypersensitive to alkylating agents (10,11).
Similarly, exposure of mammalian cells lacking
ALKBH2 to the alkylating agent methylmethane sulfon-
ate (MMS) results in increased cytotoxicity and
mutagenicity (12,13). Compared with ALKBH2 proﬁ-
cient, the deﬁcient cells are characterized with large
increase in C!A and to certain extent C!T mutations,
when treated with MMS (13). Additionally, ALKBH2 has
been implicated in cancerogenesis, by inﬂuencing cancer
progression, as well as sensitivity to cisplatin treatment
(14,15). Efﬁcient removal of alkylation DNA damage is
thus critical for cellular function, preservation of genomic
integrity and survival.
Increased cytotoxicity and mutation frequency, due to
loss of functional AlkB or ALKBH2, suggest an impaired
action of DNA polymerases (Pols) at the site of
unrepaired alkylation damage. Besides a malfunctional
direct reversal pathway, Pols can face 3meC in case: (i)
when the amount of DNA damage exceeds the cellular
repair capacity as well as (ii) if alkylation damage of
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ssDNA occurs during DNA replication or repair. Upon
encountering the DNA lesion, Pols can either (i) be com-
pletely blocked, (ii) incorporate a nucleotide opposite the
damage and then be blocked due to inability to extend or
(iii) fully bypass by base pairing and extending past the
lesion. Understanding the role(s) of the different Pols in
the bypass of alkylation damage is complicated by the
number of different Pols present in every organism, with
a broad range of catalytic properties. For example, the
prokaryotic organism E. coli contains ﬁve different Pols
(16), whereas in eukaryotes sixteen Pols have been
identiﬁed and, based on the sequence homology,
grouped in ﬁve families—A, B, X, Y and reverse tran-
scriptase (17). Addition of a methyl group to endocyclic
N-atoms and subsequent generation of 3meC, 3-
methylthymine, 1-methyladenine and 1-methylguanine
lesions leads to DNA replication block in E. coli, poten-
tially due to impairment of B-family replicative Pol III
(10). In addition, the E. coli A-family gap-ﬁlling Pol I is
inhibited by 3meC damage and besides certain incorpor-
ation of dGTP, it can misincorporate dATP and dTTP
opposite the lesion (18,19). While the replicative Pols are
characterized with a high ﬁdelity enabled by a tight-ﬁtting
active site and 30!50 proofreading activity, the active sites
of X- and Y-family translesion synthesis (TLS) Pols,
which also lack a 30!50 proofreading exonuclease
activity, can readily accommodate and efﬁciently bypass
different DNA damages. At the same time, this results in
an increased error-rate on undamaged DNA (20–22).
Accumulation of the Y-family TLS Pols, as result of
SOS-response activation in E. coli, increases bypass efﬁ-
ciency of the 3-methylpirimidine and 1-methylpurine
lesions by 3–4-fold (10,11). A recent structural study
provided valuable insight into the features of prokaryotic
Y-family Dpo4-mediated bypass of 3meC lesion (23).
Presence of 3meC results in inhibition of Dpo4 and gen-
eration of 60% mutagenic products during remaining
bypass (23). Crystal structure of Dpo4 ternary extension
complex with correct and mismatched 30-terminal primer
base opposite the 3meC lesion indicates that the lesion
remains positioned within the DNA template/primer
helix, whereas the correct as well as incorrect nucleotides
paired to 3meC are misaligned and exhibit signiﬁcant
primer terminal distortion (23). Unfortunately, similar
structural or mechanistic studies in the presence of the
blocking and mutagenic 3meC lesion with eukaryotic
Pols are currently lacking.
In this work, we characterized the impact of the 3meC
lesion on six human Pols belonging to the three families B
(Pol d), X (Pols b and ) and Y (Pols k, i and Z). The
properties of human Pols were compared on (i) running-
and standing-start templates mimicking replicative condi-
tions, as well as (ii) 29-, 7- and 1-nucleotide (nt) gap con-
structs resembling nucleotide excision (NER) and base
excision repair (BER) intermediates, respectively. By
using recombinant proteins, we show that under replica-
tive conditions, 3meC impairs human B-family, represents
a block for X-family enzymes, but can be successfully
utilized by Y-family Pols, especially Pols i and Z. Single
nucleotide incorporation experiments reveal that Pols i
and Z successfully base-pair 3meC, Pol i by preferentially
misincorporating dTTP and Pol Z dATP. The most efﬁ-
cient extenders of base-paired 3meC are Pols k and Z,
their activity depending on the DNA structure. Finally,
by using human cell extracts, we provide evidence that
in the context of the cell the Pol crucial for efﬁcient
3meC bypass is Pol Z, as its lack results in an inability
to successfully overcome the lesion. These results suggest
the existence of a novel Pol Z-dependent pathway that
could reduce the mutagenic effects of alkylation treatment
and potentially facilitate cellular survival, especially under
conditions when the functional ALKBH proteins, respon-
sible for direct reversal repair, are missing.
MATERIALS AND METHODS
Labeled g[32P] ATP was purchased from Hartmann
Analytic. Deoxyribonucleoside triphosphates were from
Sigma. All other reagents were of analytic grade and
purchased from Fluka, Sigma or Merck. The 40, 39, 35,
32, 26 and 17mer and oligonucleotides were obtained from
Microsynth, whereas 72mer containing 3meC lesion or
undamaged C were purchased were from Purimex.
Preparation of DNA substrates
The sequences of the oligonucleotides used were as
follows: 72mer template, 50GTATTAGATATTCGGGA
GGTTGGGCGCCGGCGXTGTGAATTCGGCACTG
GCCGTCGTATGCTCTTGGTTGTA30; 40mer primer,
50TACAACCAAGAGCATACGACGGCCAGTGCCG
AATTCACAN30; 39mer primer, 50TACAACCAAGAGC
ATACGACGGCCAGTGCCGAATTCACA30; 17mer
primer, 50TACAACCAAGAGCATAC30; 35mer 50AAA
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
30; 32mer 50CGCCGGCGCCCAACCTCCCGAATATC
TAATAC30; and 26mer, 50CGCCCAACCTCCCGAAT
ATCTAATAC30. The letter X corresponds to the
position of 3meC and C in the damaged and undamaged
DNA template, respectively. The letter N in 40mer indi-
cates four possible nucleotides at the primer 30 terminus:
G, A, T or C. These four different 40mers were annealed
to template strand and used in the extension assay experi-
ments (Figure 5 and Supplementary Figure S6). The
primer/template resembling running-start conditions was
generated by annealing 17mer primer and 72mer template
(Figure 1 and Supplementary Figure S1), whereas anneal-
ing of 39mer primer and the same template resulted in
standing-start situation (Figures 2, 6 and Supplementary
Figure S2). The 29-nt gap construct was created by an-
nealing 17mer primer and 26mer downstream oligonucleo-
tide to 72mer template (Figure 3 and Supplementary
Figure S3). Annealing of 39mer primer and downstream
32mer to 72mer template yielded 1-nt gap construct
(Figure 4). When instead of 32mer a 26mer was used, 7-
nt gap was generated (Supplementary Figures S4 and S5).
The 17, 39 and 40mer primers were labeled with T4
polynucleotide kinase (New England Biolabs) in the
presence of [32P] ATP. Each labeled oligonucleotide was
mixed with the 72mer template oligonucletide at 1:1
(M/M) ratio in the presence of 20mM Tris–HCl
(pH 7.4) and 150mM NaCl, heated at 95C for 10 min
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and then slowly cooled down at room temperature.
Similarly, to obtain 29-, 7- and 1-nt gap constructs,
labeled primer, template and downstream oligonucleotide
were mixed in ration 1:1:1 (M/M/M).
Expression and puriﬁcation of recombinant proteins
Human recombinant Pol d and PCNA were expressed
and puriﬁed as described in (24,25). Human recombinant
Pols  and b were puriﬁed as noted previously in (26). The
bacterial clones for the expression of human Pols Z and i
were a gift from Roger Woodgate (NIH, USA). Human
recombinant Pols Z and i were expressed and puriﬁed as
described (27). Pol k was purchased from Enzymax, USA.
Cell lines and culture conditions
XP30R0 ﬁbroblasts are simian virus 40-transformed cells
derived from a patient suffering from the variant form of
xeroderma pigmentosum (XPV). The cells harbor a 13-bp
deletion resulting in the expression of a truncated and
non-functional Pol Z. XP30R0 cell line was a gift from
Alan Lehman (University of Sussex, Brighton, UK). Cells
were grown in a humidiﬁed 5% CO2 atmosphere in
Dulbecco’s modiﬁed Eagle’s medium containing
GlutaMAX-I supplemented with 10% fetal bovine
serum and 100U/ml penicillin–streptomycin (all
obtained from Gibco, Invitrogen). To overexpress
human Pols Z and i mammalian expression vectors
pJRM56 and pJRM46 [provided by Roger Woodgate
(NIH, USA)] were used. Empty vector pcDNA 3.1
(Invitrogen), pJRM46 or pJRM56 expression constructs
were transiently transfected into XPV cells using
lipofectamine (Invitrogen) according to manufacturers
protocol. Forty-eight hours after the transfection, cells
were harvested and whole-cell extract (WCE) prepared.
Preparation of WCE
Cells were trypsinized, washed twice with cold PBS and
resuspended in three packed cell volumes of hypotonic
lysis buffer [10mM Tris–HCl (pH 8), 1mM EDTA,
10%(w/v) sucrose, 10% (v/v) glycerol, 0.1mM PMSF,
1mM DTT, 1 mg/ml pepstatine, 1 mg/ml bestatine and
1 mg/ml leupeptin]. After swelling for 20min at 4C, cells
were lysed with a Dounce homogenizer (tight pastille).
NaCl was added next to a ﬁnal concentration 0.35M
and incubated 10min at 4C. Samples were diluted with
seven packed cell volumes of lysis buffer, sonicated and
centrifuged 20min at 15 000 g. The supernatants were ﬂash
frozen in liquid N2 or analyzed directly.
Protein analysis
WCEs were separated on 10% Bis-Tris poly-acrylamide
gels followed by transfer to Immobilon-FL membrane
(Millipore) for immunoblotting analysis. Primary
antibodies against Pol Z (Abcam), Pol i [custom made
antibody, provided by Roger Woodgate (NIH, USA)]
and Tubulin (Sigma) were detected using infrared Dye-
conjugated secondary antibodies (LI-COR Biosciences).
The signal was visualized using direct infrared ﬂuores-
cence via the Odyssey Scanner (LI-COR Biosciences).
Enzymatic assays
Recombinant human enzyme assays
For denaturing gel analysis of DNA synthesis products,
the reaction mixture (10 ml) contained 40mM Tris–HCl
(pH 8), 10mM DTT and 250 mg/ml bovine serum
albumin. In case of Pol d reactions, 5mM Mg2+ was
present, whereas for all other Pols, 1mM Mg2+ was
used. Concentrations of Pols and the 50 32P-labeled
DNA in the reaction were as indicated in the Figures, as
well as Figure Legends. The amounts of dNTPs were as
follows: 10 mM for Pol d, 1 mM in case of Pol  and 5 mM
for all other Pols. All reactions were performed at 37C
for 15min, and the reaction products analyzed by 7M
urea/12.5% polyacrylamide gel electrophoresis.
Assay with WCEs
For denaturing gel analysis of DNA synthesis products,
the 10 ml of reactions containing 40mM Tris–HCl (pH 8),
10mM DTT and 250 mg/ml bovine serum albumin, 1mM
Mg2+, 2 nM 50 32P-labeled DNA, 10 mM unlabeled 35mer
trap DNA, 100 mM dNTPs and 3 ml of (1.33 mg/ml) WCE
were incubated at 37C for 30min, and reaction products
were separated by 7M urea/12.5% polyacrylamide gel
electrophoresis.
Steady state kinetic analysis
Reactions were performed as described earlier in the text,
each reaction containing 20 nM of DNA template and
15 nM of either Pol i or Z. Quantiﬁcation was performed
by densitometry with a PhosphorImager (Typhoon Trio,
GE Healthcare). The initial velocities of the reaction were
calculated from the values of integrated gel band
intensities with the programs GelEval 1.35 scientiﬁc
imaging software (FrogDance Software, UK) and
GraphPad Prism 5.0:
I T=IT 1,
where T is the target site, the template position of interest;
I*T is the sum of the integrated intensities at positions T,
T+1,. . ., T+n. All of the intensity values were normalized
to the total intensity of the corresponding lane to correct
for differences in gel loading. The apparent kM and kcat
values were calculated by plotting the initial velocities in
dependence of the nucleotide [dNTP] or primer [30-OH]
substrate concentrations and ﬁtting the data according
to Michaelis–Menten equation:
kcat½E0=ð1+kM=½SÞ,
where [E]0, was the input enzyme concentration and
[S] was the variable substrate. Substrate incorporation
efﬁciencies were deﬁned as the kcat/kM ratio. Under
single nucleotide incorporation conditions,
kcat=kpolkoff/(kpol+koff) and kM=kdkoff/(kpol+koff),
with kpol being the true polymerization rate, koff the dis-
sociation rate of the enzyme–primer complex and kd the
true Michelis constant for nucleotide binding. Thus,
kcat/kM values are equal to kpol/kd. Substrate concentra-
tions used for dNTPs were 0.1–10 mM.
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Time-dependent accumulation of products was ﬁtted to
the mixed exponential equation:
½P ¼ Að1 ekobstÞ+ksst,
where [P] designates the products formed, A the burst
amplitude, t time, kobs the apparent burst rate, and kss
the steady-state rate, which corresponds to koff.
Free energy change (G) values were estimated
according to the relationship:
G ¼ RT lnðkÞ,
where R is the gas constant (1.9872 calmol1K1), T
is the absolute temperature (K), and k is the ratio between
the kinetic constants considered.
RESULTS
The Y-family DNA polymerase g successfully
bypasses 3meC
3meC is predominantly generated in ssDNA, which is
largely present during DNA replication. To address the
impact of 3meC damage occurring directly in front of
the replication machinery, bypass efﬁciency of six
human Pols was tested under running-start conditions
(Figure 1A), using a primer/template containing the
lesion at position +23 from the primer. For efﬁcient
lesion bypass, Pols need to elongate the primer up to the
lesion, incorporate a nucleotide opposite the damage and
extend from it. The activity of the major lagging-strand
replicative Pol d was partially impaired in the presence
of 3meC damage (Figure 1B). Pol d reached the lesion
and incorporated a nucleotide opposite 3meC; however,
its further extension was reduced resulting in very limited
amount of full-length product (Figure 1B, lanes 2–4). This
suggested that, upon encountering the lesion, the replica-
tion fork could potentially be signiﬁcantly slowed-down or
stalled and for its successful continuation another more
specialized Pol would be required. The repair X-family
Pols b and  are known to bypass small base lesions
(17,20), but they were fully blocked by the 3meC
damage (Figure 1B, lanes 6–12). The three different
members of TLS Y-family Pols k, i and Z were tested
next on 3meC (Figure 1C). As a template DNA in its
sequence contains all four bases including undamaged T,
which Pol i favorably mispairs with ‘wooble’ G (28), Pol i
was unable to efﬁciently elongate the running-start primer
and reach the lesion (Figure 1C, lanes 6–8). Pol k in con-
trast very efﬁciently elongated the primer, but exhibited
strong pausing at the position immediately preceding the
lesion. It nonetheless was able to partially bypass 3meC,
by generating products one or two nucleotides shorter
than the full-length (Figure 1C, lanes 2–4). This suggested
that Pol k either loops out 3meC lesion and continues the
synthesis or generates deletions during elongation after
pairing of 3meC. To distinguish between the two, the
length of Pol k products was compared in the presence
of undamaged and damaged running-start templates
(Supplementary Figure S1A). In both cases, the products
generated by Pol k were one or two nucleotides shorter
than the full-length (Supplementary Figure S1B, compare
lanes 1–8 with lanes 9 and 10), thus indicating that under
tested conditions, Pol k most likely induces deletions
during elongation. Pol Z ﬁnally was the most efﬁcient in
bypassing 3meC under running-start conditions. Pol Z in
fact elongated the primer and efﬁciently generated full-
length product, showing only a modest pausing at the
lesion site (Figure 1C, lanes 11 and 12). Taken together,
these ﬁrst results indicated that under running-start con-
ditions, 3meC (i) blocks human X-family Pols, (ii) impairs
the activity of B-family Pol d and Y-family Pol k, but (iii)
can successfully be processed by TLS Pol Z.
DNA polymerases i and g efﬁciently, but inaccurately,
base-pair 3meC
While considering the bypass efﬁciency of a certain DNA
lesion, it is additionally essential to determine its impact
on Pol ﬁdelity. To assess the accuracy of 3meC bypass, the
primer was annealed to template strand directly in front
of the lesion resulting in standing-start conditions
(Figure 2A). The amount of dNTPs in the reaction was
modulated according to the known afﬁnity of each Pol.
Replicative Pol d under standing-start conditions prefer-
entially misincorporated dATP, followed by dTTP
opposite 3meC (Figure 2B, lanes 4 and 5). Additionally,
in the presence of all 4 dNTPs, Pol d incorporated a single
nucleotide opposite the lesion and in comparison with
control template exhibited dramatically reduced extension
capacity (Figure 2B, lane 2; Supplementary Figure S2),
thus conﬁrming the observation from Figure 1B. The
presence of 3meC on standing-start primer/template
strongly inhibited the activity of Pols b and , as well as
k (Figure 2C–E). Interestingly, Pol k weakly inserted two
dCTPs (Figure 2E, lane 6), suggesting that under
standing-start conditions, this Pol either (i) potentially
skips 3meC and copies the next template base (G) twice
or (ii) incorporates ﬁrst dCTP opposite the lesion and the
second one across subsequent template base. In compari-
son with other human Pols tested, the Y-family Pols i and
Z efﬁciently base paired the lesion (Figure 2F and G).
Interestingly, Pol i more efﬁciently incorporated dGTP
opposite 3meC, than across undamaged C (Figure 2F,
compare lane 1 with lane 3). While Pol i successfully
mispaired 3meC with dTTP, Pol Z with comparable efﬁ-
ciency incorporated the inaccurate dATP as well as the
correct dGTP opposite 3meC (Figure 2F and G;
Table 1). In addition, it also showed a low discrimination
against the incorporation of dTTP and dCTP (Table 1).
Similar to Pol k, in the presence of dCTP incorporation of
two nucleotides was observed (Figure 2G, lane 6).
Suggesting that Pol Z after copying the lesion incorporates
second dCTP opposite the next template base or that it
skips 3meC and copies subsequent template G twice.
Overall, the substrate afﬁnity and conversion efﬁciency
were several fold higher for Pol Z than i (Table 1). Pol
Z further completed the bypass by generating full-length
products in the presence of all 4 dNTPs (Figure 2G, lane
2). These ﬁndings suggested that Y-family Pols i and Z
efﬁciently misincorporate nucleotides opposite 3meC, with
Pol Z being the more accurate of the two.
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DNA polymerase g is the most proﬁcient in ﬁlling 3meC
containing DNA gaps, mimicking NER and BER
intermediates
In addition to DNA replication, ssDNA regions fre-
quently exist in the shape of gap intermediates produced
during repair processes such as NER and BER.
Generation of alkylation damage while the NER or
BER machineries are still processing these ssDNA gaps
would require lesion bypass for efﬁcient gap closure. To
determine the ability of Pols to close NER gap intermedi-
ate containing a lesion, a 29-nt gap construct with 3meC at
position +23 was generated. As the presence of a phos-
phate group can dramatically affect bypass efﬁciency of
certain Pols (29), the 50-terminus of the gap was either
phosphorylated (Figure 3A) or not (Supplementary
Figure S3A). As expected, titration of Pol d revealed
that this Pol efﬁciently reached the 3meC, was able to
incorporate a nucleotide opposite the lesion, but was
poor in subsequent extension, resulting in inefﬁcient gap
ﬁlling independently of the gap 50-end phosphorylation
status (Figure 3B and Supplementary Figure S3B).
While Pol b was once more blocked by 3meC, Pol ,
another X-family member, efﬁciently closed the 29-nt
gap, when the 50-end of the gap was phosphorylated, but
not when the phosphate group was lacking (Figure 3B,
lane 12 compare with Supplementary Figure S3B, lane
12). Interestingly, Pol  predominately generated
products one nucleotide shorter than the gap size
(Figure 3B, lane 12), indicating that it either stops just
before the 50-end of the gap or it generates single
Figure 1. 3meC bypass by six human DNA polymerases under running-start conditions. (A) Schematic representation of running-start
primer template containing 3meC lesion designated as X. Numbers above the template indicate the positions of template bases with respect
to the lesion. FL stands for full-length. (B, C) Titration of Pols d, b,  (B) and Pols k, i, Z (C) under running-start conditions in
the presence of 2 nM DNA and indicated PCNA amounts. The experiments were done under conditions as described in ‘Materials and Methods’
section.
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nucleotide deletions, potentially by looping out the lesion.
Similarly to running start conditions, Pol i was not able to
reach the lesion (Figure 3C and Supplementary Figure
S3C). Pol k showed a strong pausing site immediately
before the lesion but was eventually able to close the
gap containing both non- and phosphorylated 50-end
(Figure 3C and Supplementary Figure S3C), as well as
continuing up to the end of the template, displacing the
downstream strand. Pol Z on the other hand efﬁciently
bypassed the lesion and completely ﬁlled the gap
Figure 2. Efﬁciency and ﬁdelity of six human DNA polymerases on the 3meC template under standing-start conditions. (A) Standing-start primer
template with undamaged C or 3 meC lesion designated as X. Numbers above the template indicate the position of template bases with respect to the
lesion at+1. FL is full-length product. (B–G) Extension of the 2 nM standing-start primer template by 2 nM Pol d in the presence of 100 nM PCNA
(B), 2 nM Pol b (C), 2 nM Pol  (D), 2 nM Pol k (E), 2 nM Pol i (F) and 2 nM Pol Z (G). Reactions in lanes 1 and 3–6 contain dGTP, dATP, dTTP
and dCTP, respectively. In lane 2, all four dNTPs (N) were added. The experiments were performed under conditions as speciﬁed in ‘Materials and
Methods’ section.
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(Figure 3C and Supplementary Figure S3C). It also
showed robust strand displacement of both
phosphorylated and non-phosphorylated 50-gap oligo-
nucleotide (Figure 3C and Supplementary Figure S3C).
Next, the efﬁciency and accuracy of 3meC bypass were
addressed on a shorter 7-nt gap template, mimicking
a long-patch BER intermediate, with phosphorylated
(Supplementary Figure S4A) or non-phosphorylated
Figure 3. Synthesis by six human DNA polymerases past a 3meC lesion in the context of a NER intermediate. (A) Schematic representation of 29-nt
gap template containing a 3meC lesion designated as X. Numbers indicate the position of template bases with respect to the lesion. FL stands for
full-length product generated after strand displacement. (B, C) Titration of Pols d, b,  (B) and Pols k, i, Z (C) in the presence of 2 nM DNA and
indicated PCNA amounts. The experiments were done under conditions as described in ‘Materials and Methods’ section.
Table 1. Kinetic parameters for nucleotide incorporation by DNA polymerases i and Z opposite 3meC in the template
Pol i Pol Z
dNTP kM (mM) kcat (ms
1) kcat/kM (M
1s1) Fidelitya kM (mM) kcat (ms
1) kcat/kM (M
1s1) Fidelitya
dGTP 6 0.3 0.05 103 2 0.6 0.31 103
dATP n.a. n.a. n.a. n.a. 1.5 0.7 0.46 103 0.7
dTTP 12.64 0.9 0.07 103 0.7 18.4 0.7 0.04 103 8.9
dCTP 3.5 0.2 0.05 103 0.9 2.4 0.3 0.14 103 2.2
Not accessible values designated as n.a.
aCalculated as Vmax/kM(dGTP)/Vmax/kM(d A/T/CTP).
The experiments were done under conditions as speciﬁed in ‘Materials and Methods’ section.
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(Supplementary Figure S5A) 50-gap terminus and bearing
the lesion at position+1. B-family Pol d was impaired by
3meC lesion, irrespectively of the 50-gap status and only
weakly misincorporated dATP and dTTP, being then
unable to continue synthesis (Supplementary Figures
S4B and S5B). Even though Pol b is suited to ﬁll short
gaps, the presence of 3meC entirely blocked its activity
(Supplementary Figures S4C and S5C). Pol k was com-
pletely blocked with 50-phosphorylated gap
(Supplementary Figure S4E) and showed only a very
weak activity on the unphosphorylated substrate
(Supplementary Figure S5E). In contrast, Pol Z again ef-
ﬁciently closed the gap, incorporating mainly the incorrect
dATP and correct dGTP opposite the lesion, as well as to
a lesser extent dCTP and dTTP (Supplementary Figures
S4G and S5G). Pols  and i mispaired 3meC with dCTP
(Supplementary Figure S4D, lane 6) and dTTP
(Supplementary Figure S4F, lane 5 and Supplementary
Figure S5F, lane 5), respectively. In comparison to
standing-start conditions (Figure 2F), the presence of
3meC did not stimulate Pol i activity. While Pol i was
unable to close the gap (Supplementary Figures S4F and
S5F, lane 2), Pol  after dCTP misincorporation reached
the end of the gap, albeit with low efﬁciency and only
when 50 gap terminus was phosphorylated (compare
Supplementary Figure S4D, lanes 2 and 6 to
Supplementary Figure S5D, lanes 2 and 6). As under
standing-start conditions Pol  could not bypass 3meC
(Figure 2D), the present observation raised the possibility
that in the context of short-gap 3meC is not directly
mispaired with dCTP, but instead that Pol  uses its
ability to scrunch the template (30) and loop out the
lesion, thus incorporating dCTP opposite template G at
position+1. However, it is also possible that the presence
of the 50-phosphate, which is known to increase the efﬁ-
ciency of Pol , may allow direct incorporation opposite
the lesion.
DNA polymerases i and g can ﬁll a single-nucleotide gap
positioned opposite 3meC
While long-patch BER is more common during replication,
the majority of BER reactions in G1/G2 phases give raise
to ssDNA in shape of a 1-nt gap intermediate, as a conse-
quence of the combined glycosylase and AP endonuclease
action. Thus, we next tested the ﬁdelity on a template con-
taining a 1-nt gap positioned opposite 3meC (Figure 4A)
and bearing a 50-phosphorylated end. Replicative Pol d was
as expected impaired at this template and extremely poorly
misincorporated dATP and dTTP opposite the lesion
(Figure 4B). Pol b was unable to act at the site of 3meC
damage, even under these classical BER conditions
(Figure 4C). Surprisingly, Pol  that is known to efﬁciently
perform TLS on 1-nt gap (26,31) was blocked in the
presence of 3meC. This suggested that during copying of
the larger 7- and 29-nt gaps (Figure 3 and Supplementary
Figure S4) Pol  scrunched the template, looped out the
damaged nucleotide, elongated and consequently induced
single nucleotide deletions. From the Y-family enzymes,
Pol k did not act on the lesion template (Figure 4E),
whereas Pol i and Z efﬁciently ﬁlled the gap. Pol i
misincorporated dTTP (Figure 4F, lane 5) and its
activity, similarly to 7-nt gap (Supplementary Figures S4
and S5), was not stimulated by 3meC. Thus, suggesting that
presence of the lesion stimulates Pol i activity only in rep-
licative context (Figure 2F). Pol Z on 1-nt gap template
incorporated the correct dGTP, as well as the incorrect
dATP (Figure 4G, lanes 3 and 4). Interestingly, on this
template, no incorporation of dTTP or dCTP by Pol Z
was noted, contrary to what was observed under
standing-start conditions and with the longer gaps.
Further implying that the previously detected dCTP and
dTTP incorporation by Pol Z (Figures 2G,
Supplementary Figure S4G and S5G), as well as dCTP
by Pol k (Figure 2E) resulted from incorporation
opposite alternative templating bases, which cannot take
place in a 1-nt gap. When all 4 dNTPs were present in
the reaction Pol Z generated a+1 product with electrophor-
etic mobility more similar to that of dATP than dGTP,
indicating potentially inaccurate bypass of 3meC in a 1-nt
gap (Figure 4G, compare lanes 2, 3 and 4). Taken together,
as in the case of the previously used standing-start and
gapped templates, Pols i and Z were the most proﬁcient
Pols in performing TLS over a 3meC lesions.
DNA polymerases i and g are best extenders from 3meC
In many cases, TLS is a two-step process involving incorp-
oration of a nucleotide opposite a lesion by a certain Pol
and subsequent extension of the primer by a specialized
extender Pol. To test the extension properties of different
Pols, a primer/template ending with either the correct
G:3meC or the three incorrect A:3meC, T:3meC or
C:3meC base pairs was created (Figure 5A). All six
tested human Pols successfully utilized the control C:G
substrate, however with different efﬁciencies (Figure 5B,
lanes 2–7). In presence of the lesion, Pol d only weakly
extended T:3meC and C:3meC containing constructs
(Figure 5B, lanes 23 and 30). In contrast, Pols k and Z
utilized both correctly, as well as all three incorrectly
primed lesion templates (Figure 5B, lanes 12, 14, 19, 21,
26, 28, 33 and 35) and from all the six Pols tested were the
two most efﬁcient in extending all the substrates. While
Pol Z generated full-length products, Pol k in contrary
created products one or two nucleotides shorter than the
full-length (Figure 5B, lanes 12,19, 26 and 33), in agree-
ment with its tendency to introduce 1 deletions (32).
To address whether the observed extension capacity was
construct dependent, we next generated a 6-nt gap with
either correct G:3meC or incorrect A:3meC, T:3meC and
C:3meC base pair located at the 30-end of the gap
(Supplementary Figure S6A). From these substrates, Pol
d only poorly processed A:3meC, C:3meC and T:3meC
gaps (Supplementary Figure S6B, lanes 16, 23 and 30).
Pol  on the other hand was able to extend all lesion con-
structs and close 6-nt gap (Supplementary Figure S6B).
Similarly, Pols k and Z acted on all the templates and, as
with the previous substrates, were the most efﬁcient exten-
ders. Interestingly, under the 6-nt gap condition, Pol k was
the most active especially if gap contained T:3meC or
C:3meC (Supplementary Figure S6B, lanes 26 and 33).
Pol Z, as well as Pol k but only on the T:3meC substrate,
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displayed a robust strand displacement activity. In case of a
C:3meC template, both Pols  and k predominantly
generated ﬁve nucleotides long product, a patch one nu-
cleotide shorter than the gap itself, thus indicating that
both Pols potentially re-prime the template by repositioning
the 30 C and base-pairing it with G at position+1 from the
lesion. In summary, these ﬁndings indicated that Pols k and
Z are the most efﬁcient extenders of 3meC, and that their
activity is inﬂuenced by the structure of the DNA construct.
Efﬁcient bypass of 3meC in human WCEs requires the
presence of a functional DNA polymerase g
So far in the experiments testing recombinant human
enzymes, we demonstrated that Pol i successfully
incorporated a nucleotide opposite 3meC, whereas Pol Z
was more efﬁcient in extending a mismatched primer con-
taining 3meC. Uniquely, among all Pols tested, Pol Z was
efﬁcient in both: (i) incorporation opposite the lesion as
well as (ii) subsequent extension (Figures 1–5). To verify
whether Pol Z was indeed playing a major role in 3meC
bypass, even in the presence of other Pols such as in the
context of a whole cell, we tested the ﬁdelity and bypass
capacity of various cellular extracts under standing-start
conditions (Figure 6A). WCEs were prepared from XPV
patient cells lacking endogenous functional Pol Z. XPV
cells were complemented with either (i) empty vector, (ii)
human Pol Z or (iii) Pol i expression constructs
(Figure 6B). Interestingly, although all three WCEs were
comparably active on a control template containing un-
damaged C (Figure 6C, lanes 1, 7 and 13), only WCE
prepared from XPV cells that had been complemented
with Pol Z showed robust incorporation opposite 3meC
(Figure 6C, lanes 8–12). As with the recombinant enzyme
(Figure 2G), Pol Z complemented WCE predominantly
incorporated dATP and dGTP opposite the 3meC
(Figure 6C, lanes 9 and 10). In the presence of 4 dNTPs,
+1 product with electrophoretic mobility similar to the
one of A incorporated opposite the lesion was obtained
Figure 4. Ability of six human DNA polymerases to close a single nucleotide gap generated opposite a 3meC damage. (A) A 1-nt gap template with
undamaged C or 3meC lesion (X) positioned directly opposite the gap. (B–G) Filling of the 2 nM gapped DNA template depicted in (A) by 2 nM Pol
d in the presence of 100 nM PCNA (B), 2 nM Pol b (C) 2 nM Pol  (D), 2 nM Pol k (E), 2 nM Pol i (F) and 5 nM Pol Z (G). Reactions in lanes 1 and
3–6 contain dGTP, dATP, dTTP and dCTP, respectively. In lane 2, all four dNTPs (N) were added. The experiments were done under conditions as
speciﬁed in ‘Materials and Methods’ section.
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(Figure 6C, compare lanes 8 and 10). This suggested that
Pol Z potentially bypasses 3meC in an inaccurate manner
and further coincided with the results of reactions using
only the puriﬁed protein (Figure 4G). Pol Z mediated
bypass in context of WCE was partially efﬁcient, due to
low amount of extension product generated (Figure 6C,
lane 8). We thus hypothesized that the simultaneous
increase in the amounts of (i) Pol i as inserter and (ii)
Pol Z as both inserter and extender of 3meC could
improve the bypass efﬁciency. Expression of both Pols
in XPV cells (Figure 6B) resulted in promoted incorpor-
ation of all 4 nucleotides (Figure 6C, lanes 21–24), as well
as an increased amount of extension product (Figure 6C,
compare lanes 8 and 20), overall leading to improved
3meC bypass efﬁciency. Taken together these ﬁndings
clearly indicated that the presence of functional Pol Z in
human cells is crucial for 3meC bypass, which can be
mediated by either Pol Z alone or as a two-step process
involving an additional Pol, such as Pol i.
DISCUSSION
Exposure of genomic DNA to alkylating agents results in
generation of numerous DNA lesions. While the pathways
to repair alkylating DNA lesions are well characterized,
much less is known about the inﬂuence of alkylation
damage on different Pols. Several studies described the
properties of prokaryotic Pols on the alkylation lesion
3meC; however, it is currently unknown how this
damage affects eukaryotic Pols. In this work, we
Figure 5. Extension of accurately base-paired and mispaired 3meC primer/templates by six human DNA polymerases. (A) Representation of
incorrectly (Y=A, T or C) as well as correctly (Y=G) paired primer termini on control (X=C) and lesion (X=3meC) DNA. Numbers
above the template indicate the position of template bases with respect to the lesion at+1. (B) Extension of the 2 nM DNA template schematically
represented above the lanes by 5 nM Pol d in the presence of 100 nM PCNA, 4 nM Pol b, 7 nM Pol , 4 nM Pol k, 30 nM Pol i and 20 nM Pol Z.
The experiments were performed under conditions as described in ‘Materials and Methods’ section.
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characterized the properties of 3meC bypass by the six
human Pols d, b, , k, i and Z, members of the
B-, X- and Y-families. Our ﬁndings strongly suggest that
among the six tested enzymes, PolZ most efﬁciently
bypassed 3meC On open or long gapped substrates, Pol
Z-mediated 3meC bypass was error-prone, leading to the
incorporation of almost all four nucleotides with selectiv-
ity indexes ranging from 0.7 (for dATP) to 9 (for dTTP)
with respect to the correct dGTP (Table 1). However, on
single nucleotide gapped substrates, incorporation was re-
stricted to dATP and dGTP (Figure 4G). Besides its
ability to incorporate the incorrect dATP, as well as the
correct dGTP opposite 3meC, Pol Z efﬁciently extended
both correctly and incorrectly paired primer termini on
lesion DNA. Pol Z was unique among all the tested Pols
in combining the properties of both an inserter and
Figure 6. Only cells expressing DNA polymerase Z are able to successfully overcome 3meC damage. (A) Schematic representation of standing-start
primer template with undamaged C or 3meC lesion designated as X. Numbers above the template indicate the position of template bases with respect
to the lesion at+1. FL is full-length product. (B) Immunoblot analysis of XPV WCE complemented with empty vector, Pol Z, Pol i or Pols Z and i
expression vectors. (C) Bypass capacity of 3meC lesion by XPV, XPV Pol Z, XPV Pol i, as well as XPV Pols Z and i complemented extracts.
The experiments were done under the conditions speciﬁed in ‘Materials and Methods’ section.
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extender. We further conﬁrmed its importance in the
context of a whole cell; by showing that lack of Pol Z in
human cell extracts results in a severely reduced ability to
act at the site of 3meC (Figure 6C). The importance of
functional Pol Z in response to monoalkylating agents
has been already suggested by in vivo experiments
showing that the Saccharomyces cerevisiae rad30D strain
lacking Pol Z is somewhat sensitive to MMS (33,34).
Furthermore, MMS treatment of human cells was
shown to result in formation of Pol Z foci at the site of
replication forks blocked by alkylation lesions (35), one of
which is potentially 3meC. In addition to Pol Z, another
Y-family member, Pol i efﬁciently bypassed 3meC by pref-
erentially misincorporating dTTP opposite the lesion but
was unable to extend it. In the context of WCEs, an
increase in the level of Pol i as inserter resulted in
promoted Pol Z-mediated 3meC bypass (Figure 6C).
Interestingly, another Y-family enzyme, Pol k, was a
poor inserter but proved to be the most efﬁcient in extend-
ing from a T:3meC mismatch. Although the generation of
G:3meC pair by Pol Z would create another chance for
ALKBH2 to repair and thus remove lesion from the
genome, it is currently not clear which consequences the
persistence of A:3meC, as well as T:3meC, created by Pol
Z and i respectively, would have on genome stability. If
repair of A:3meC and T:3meC would be possible by
ALKBH2 proteins, it would result in harmful mismatches
and could potentially lead to mutations in the next round
of DNA replication. Generation of mismatches would be
especially detrimental in tissues lacking functional
mismatch repair, as was observed for various tumour
types (36,37). To prevent genomic instability in precancer-
ous tissues, it would thus be crucial to activate a Pol that
can rather faithful bypass 3meC, such as Pol Z.
Under replicative conditions, 3meC impaired the
activity of the B-family replicative Pol d and blocked the
repair Pols b and  (Figure 1B). A similar ﬁnding was seen
upon 3meC extension, condition under which Pol d only
very weakly generated full-length product. Thus suggest-
ing that, upon encountering the lesion, the replication fork
could potentially be stalled and for its successful continu-
ation, another more specialized Pol, like Pol Z, would be
required. These results correlate well with ﬁndings
obtained in prokaryotes demonstrating impeded activity
of Pols I and III at the site of 3meC (10,18,19).
Interestingly, though Pol  was unable to directly incorp-
orate nucleotides opposite the lesion, in the context of
gapped DNA, larger than 1 nt, this Pol successfully
scrunched the template and continued the synthesis by
pairing the incoming nucleotide with the template base
at+1 position from the lesion. The property of Pol  to
scrunch the template was directly shown by the crystal
structure published previously by Garcia-Diaz et al. (30).
Also, when the terminal nucleotide of the primer was com-
plementary to the nucleotide immediately downstream the
lesion, Pol  was able to loop out 3meC and use the base
downstream to re-align the primer. This slippage ability of
Pol  has been already observed for other lesions (38). In
both cases, the result was a 1-nt deletion.
Based on our ﬁndings, we propose a model for 3meC
bypass in context of DNA replication (Figure 7). When
the lesion is not repaired by ALKBHs and remains present
in the template strand, Pols might handle it in one of the
following ways: (1) after copying 3meC by incorporating
inaccurate dATP or dTTP, the replicative Pol d is stalled,
and TLS Pol Z is recruited to extend the mispair
(Figure 7-1); (2) the replication fork is stalled in front
of 3meC leading to Pol Z recruitment, predominant inser-
tion of dATP opposite the lesion and the extension
(Figure 7-2); (3) the replication fork is stalled in front of
3meC, Pol i is recruited to tolerate the lesion by
misincorporating dTTP and Pol Z to extend the newly
Figure 7. Model of 3meC bypass during DNA replication. If 3meC lesion (designated as X) is not repaired by ALKBHs and it remains present in
the template strand, Pols might handle it in one of the following ways: (1) after copying 3meC, by predominantly incorporating inaccurate dATP or
dTTP, replicative Pol d is stalled and TLS Pol Z is recruited to extend the mispair; (2) the replication fork is stalled in front of 3meC leading to Pol Z
recruitment, insertion of dATP opposite the lesion and the extension; (3) the replication fork is stalled in front of 3meC, Pol i is recruited to tolerate
the lesion by incorporating dTTP and Pol Z to extend the newly formed T:3meC base-pair. For simplicity, only nucleotides preferentially
incorporated by each of the Pols are depicted.
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formed T:3meC base-pair (Figure 7-3). In summary,
our ﬁndings suggest the potential existence of novel Pol
Z-dependent pathway that would enable cells to overcome
cytotoxic effects of alkylating agents, even at the cost
of potentially causing mutations, especially in the
absence of functional direct reversal proteins.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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